Cardiac autophagy

Good with the bad

Oktay F. Rifki, Joseph A Hill

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Stress-induced hypertrophic growth of the myocardium is a pathogenetic milestone in the progression of heart failure. Some evidence suggests that suppression of pathological cardiac hypertrophy per se is a viable target for therapeutic intervention, and cardiomyocyte autophagy is an attractive mechanism for consideration as a means of controlling the hypertrophic response. However, although considerable insights have been gleaned in the molecular mechanisms governing cardiomyocyte autophagy, many details critical to rational targeting of the response remain unknown. Among them, mechanisms underlying the adaptive and maladaptive features of autophagy are obscure. With time and further study, it is possible that this near-ubiquitous cardiac response to stress will emerge as a target for therapeutic manipulation.

Original languageEnglish (US)
Pages (from-to)248-252
Number of pages5
JournalJournal of Cardiovascular Pharmacology
Volume60
Issue number3
DOIs
StatePublished - Sep 2012

Fingerprint

Autophagy
Cardiac Myocytes
Cardiomegaly
Myocardium
Heart Failure
Therapeutics
Growth

Keywords

  • autophagy
  • cardiac hypertrophy
  • heart failure
  • myocardial ischemia
  • therapeutics

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this

Cardiac autophagy : Good with the bad. / Rifki, Oktay F.; Hill, Joseph A.

In: Journal of Cardiovascular Pharmacology, Vol. 60, No. 3, 09.2012, p. 248-252.

Research output: Contribution to journalArticle

Rifki, Oktay F. ; Hill, Joseph A. / Cardiac autophagy : Good with the bad. In: Journal of Cardiovascular Pharmacology. 2012 ; Vol. 60, No. 3. pp. 248-252.
@article{8db7c5b5cd514f2584cb1f04c0dee4cf,
title = "Cardiac autophagy: Good with the bad",
abstract = "Stress-induced hypertrophic growth of the myocardium is a pathogenetic milestone in the progression of heart failure. Some evidence suggests that suppression of pathological cardiac hypertrophy per se is a viable target for therapeutic intervention, and cardiomyocyte autophagy is an attractive mechanism for consideration as a means of controlling the hypertrophic response. However, although considerable insights have been gleaned in the molecular mechanisms governing cardiomyocyte autophagy, many details critical to rational targeting of the response remain unknown. Among them, mechanisms underlying the adaptive and maladaptive features of autophagy are obscure. With time and further study, it is possible that this near-ubiquitous cardiac response to stress will emerge as a target for therapeutic manipulation.",
keywords = "autophagy, cardiac hypertrophy, heart failure, myocardial ischemia, therapeutics",
author = "Rifki, {Oktay F.} and Hill, {Joseph A}",
year = "2012",
month = "9",
doi = "10.1097/FJC.0b013e3182646cb1",
language = "English (US)",
volume = "60",
pages = "248--252",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Cardiac autophagy

T2 - Good with the bad

AU - Rifki, Oktay F.

AU - Hill, Joseph A

PY - 2012/9

Y1 - 2012/9

N2 - Stress-induced hypertrophic growth of the myocardium is a pathogenetic milestone in the progression of heart failure. Some evidence suggests that suppression of pathological cardiac hypertrophy per se is a viable target for therapeutic intervention, and cardiomyocyte autophagy is an attractive mechanism for consideration as a means of controlling the hypertrophic response. However, although considerable insights have been gleaned in the molecular mechanisms governing cardiomyocyte autophagy, many details critical to rational targeting of the response remain unknown. Among them, mechanisms underlying the adaptive and maladaptive features of autophagy are obscure. With time and further study, it is possible that this near-ubiquitous cardiac response to stress will emerge as a target for therapeutic manipulation.

AB - Stress-induced hypertrophic growth of the myocardium is a pathogenetic milestone in the progression of heart failure. Some evidence suggests that suppression of pathological cardiac hypertrophy per se is a viable target for therapeutic intervention, and cardiomyocyte autophagy is an attractive mechanism for consideration as a means of controlling the hypertrophic response. However, although considerable insights have been gleaned in the molecular mechanisms governing cardiomyocyte autophagy, many details critical to rational targeting of the response remain unknown. Among them, mechanisms underlying the adaptive and maladaptive features of autophagy are obscure. With time and further study, it is possible that this near-ubiquitous cardiac response to stress will emerge as a target for therapeutic manipulation.

KW - autophagy

KW - cardiac hypertrophy

KW - heart failure

KW - myocardial ischemia

KW - therapeutics

UR - http://www.scopus.com/inward/record.url?scp=84866316328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866316328&partnerID=8YFLogxK

U2 - 10.1097/FJC.0b013e3182646cb1

DO - 10.1097/FJC.0b013e3182646cb1

M3 - Article

VL - 60

SP - 248

EP - 252

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 3

ER -